日本語 >>
TOP page
Journal
Presentation
（Last updated : 2024-02-02 10:49:55）
Tomohiro Tanikawa
Department
Kawasaki Medical School Kawasaki Medical School, Department of General Internal Medicine 2,
Position
Assistant Professor
■
Journal
1.
2023/09/01
Lean non-alcoholic fatty liver disease: Age-dependent differences in pathology, prognosis, and liver-related events
2.
2023/08/12
Brain activity in response to food images in patients with irritable bowel syndrome and functional dyspepsia
3.
2023/05/10
Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis
4.
2022/06/07
Two Cases of Acute Gastric Mucosal Lesions Due to
Helicobacter pylori
Infection Confirmed to be Transient Infection
5.
2022/05/11
Severe grade of melanosis coli is associated with a higher detection rate of colorectal adenoma
6.
2022/05/05
Asymptomatic gangrenous cholecystitis diagnosed using contrast-enhanced ultrasonography in a patient with pancreatic cancer
7.
2022/04/12
Efficacy of primary drainage by endoscopic ultrasound-guided biliary drainage for unresectable pancreatic adenocarcinoma
8.
2022/03
Afferent-Loop Syndrome Treated with Endoscopic Ultrasound-Guided Drainage of the Afferent Loop with a Plastic Stent
9.
2021/10/18
Increased Colonic Fluorodeoxyglucose Uptake in Melanosis Coli—A Case Series of Three Patients
10.
2021/08/06
Surgical retrieval under general anesthesia of an inadvertent denture ingestion causing cervical esophageal perforation
11.
2021/05/27
Combination of type Ⅳ collagen 7S, albumin concentration, and platelet count predicts prognosis of non-alcoholic fatty liver disease
12.
2021/05/01
Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years.
13.
2021/04/01
Gastric Hyperplastic Polyps after Argon Plasma Coagulation for Gastric Antral Vascular Ectasia in Patients with Liver Cirrhosis-A Case Suggesting the "Gastrin Link Theory".
14.
2021/02/18
Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis
15.
2021
A Case of Successful Colon Stenting for Abscess due to Gallbladder Colon Fistula Caused by Gallbladder Cancer
16.
2020/09/04
Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals:A Cross-Sectional Study
17.
2020
Efficacy and safety of temporary biliary stent for prevention of post-ERCP cholangitis after endoscopic common bile duct stone removal :a retrospective study
18.
2019/10/15
High Prevalence of Autoimmune Gastritis in Patients with Nonalcoholic Steatohepatitis
19.
2017/10
Effective Biomarkers for advance fibrosis NASH and reflect biomarkers as changes of liver fibrosis with NASH
20.
2017/10
Prediction of hepatocellular carcinoma following direct-acting antiviral treatment for chronic hepatitis C
21.
2017/10
Sequential PEG-IFNa-2a and TDF+PEG-IFNa-2a combination therapy after long-term nucleic acid analog treatment effectively reduce hepatitis B surface antigten levels
22.
2016/11
The association with non-alcoholic steatohepatitis and autoimmune gastritis-Coincidence or true nature?
23.
2016/11
The role of Kyoto classification for the diagnosis of Helicobacter pylori infection in young patients
24.
2016/10
Elevated WFAM2BP, ALT flare and HBs decline>1.0Log/ml during Peg IFN were predict drug free and HBs antigen clearance in sequential therapy with Peg-IFN alfa-2a on long-term nucleoside analog treated patients
25.
2016/10
The level of the macrophage activation marker soluble CD163 is apredictor of fibrosis progression and inflammation in non-alcoholic steatohepatitis(NASH)
26.
2016/10
The level of WFA+M2BP levels and alpha-fetoprotein levels are predicted hepatocellular carcinoma after sustained virologic response with chronic hepatitis C patients
27.
2016/06
Herpetic esophagitis following bendamustine-containing regimen
28.
2015
Elevated Serum Levels of M2BPGI Predict the Burned Out NASH and Hepatocellular Carcinoma with Non-Alcoholic Steatohepatitis
Display 5 items
Display all(28)
■
Presentation
1.
2023/09/07
Lean nonalcoholic steatotic liver disease: Age-dependent differences in pathology, prognosis, and liver-related events （Poster notice）
2.
2022/11/05
Characteristics of patients with hepatocellular carcinoma that developed following a diagnosis of nonalcoholic steatohepatitis by liver biopsy （Poster notice，Panelist at Symposium/Workshop (Applied)）
3.
2018/11/09
Combination of shear-wave elastography and liver fibrosis markers predicts severe fibrosis in patients with non-alcoholic steatohepatitis （Poster notice，Panelist at Symposium/Workshop (Applied)）
4.
2018/06/02
EVALUATION OF THE PRECUTTING TECHNIQUES FOR DIFFICULT BILIARY CANNULATION TO A MAJOR PAPILLA AROUND A DIVERTICLE （Speech，General）
5.
2018/06/02
「EVALUATION OF THE PRECUTTING TECHNIQUES FOR DIFFICULT BILIARY CANNULATION TO A MAJOR PAPILLA AROUND A DIVERTICLE」 （Poster notice，General）
6.
2017/11/01
METACHRONOUS DEPLOYMENT OF FOUR PLASTIC AND FOUR METALLIC STENTS IN THE PATIENT WITH HILAR BILE DUCT CARCINOMA SUCCESSFULLY ACHIEVED ONLY VIA ENDOSCOPIC PROCEDURE. （Speech，General）
7.
2017/10/23
Effective Biomarkers for advance fibrosis NASH and reflect biomarkers as changes of liver fibrosis with NASH （Poster notice，General）
8.
2017/10/23
Sequential PEG-IFNa-2a and TDF+PEG-IFNa-2a combination therapy after long-term nucleic acid analog treatment effectively reduce hepatitis B surface antigten levels （Poster notice，General）
9.
2017/10/21
Prediction of hepatocellular carcinoma following direct-acting antiviral treatment for
chronic hepatitis C （Poster notice，General）
10.
2017/05/08
Endoscpic findings by Kyoto classification is useful to detect Helicobacter pylori. （Poster notice，General）
11.
2016/11/12
The level of WFA+M2BP levels and alpha-fetoprotein levels are predicted hepatocellular carcinoma after sustained virologic response with chronic hepatitis C patients （Speech，General）
12.
2016/11/11
Elevated WFAM2BP, ALT flare and HBs decline>1.0Log/ml during Peg IFN were predict drug free and HBs antigen clearance in sequential therapy with Peg-IFN alfa-2a on long-term nucleoside analog treated patients （Speech，General）
13.
2016/11/11
The level of the macrophage activation marker soluble CD163 is apredictor of fibrosis progression and inflammation in non-alcoholic steatohepatitis(NASH) （Speech，General）
14.
2016/11/05
The association with non-alcoholic steatohepatitis and autoimmune gastritis-Coincidence or true nature? （Speech）
15.
2016/11/03
The role of Kyoto classification for the diagnosis of Helicobacter pylori infection in young patients （Speech）
16.
2016/08/05
The pancreatic duct stent prevents post-ERCP pancreatitis effectively in the patients with naive papilla （Speech，General）
17.
2016/05/24
Needle knife precutting papillotomy dose'nt seem to be a risk factor of post ERCP pancreatitis at the selective biliary deep cannulation. （Poster notice，General）
18.
2015/07/03
Elevated serum levels of M2BPGi predict the burned out NASH and Hepatocellular carcinoma with Non-alcoholic steatohepatitis （Speech，General）
Display 5 items
Display all(18)
